Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation for Chemotherapy Side Effects in Breast Cancer
NCT06642441Phase 3Recruiting
- Start
- Dec 2024
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in breast cancer. Started Dec 2024; status: recruiting.
02
Drugs
vitamin d
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06642441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06642441.